HUT compared with CAI: revenue, margins and what each company keeps, and the suppliers and customers both name

HUTHut 8 Corp.

Mkt capRevenueRevenue

CAICaris Life Sciences, Inc.

Mkt capRevenueRevenue

Compare

HUTHut 8 Corp.

CAICaris Life Sciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

HUT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▼−9.74%×0.62

May 6 '26±8.4%▲+35.31%×4.20

Q1 FY26±11.1%▼−6.57%×0.59

Q3 FY25±12.9%▼−12.53%×0.97

CAI1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±19.9%▲+21.58%×1.09

= impliedHUT realized, solidCAI realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

HUTHut 8 Corp.

55.00▼−7.41%· post 55.28· delayed

Mkt cap$7.3BRevenue$75MQ2 FY26Revenue$235MFY25

CAICaris Life Sciences, Inc.

32.08▼−6.56%· post 32.08· delayed

After hoursNov 2 '26delayed

Mkt cap$9.7BRevenue$264MQ2 FY26Revenue—

Compare

After hoursNov 2 '26delayed

HUTHut 8 Corp.

CAICaris Life Sciences, Inc.

55.00▼−7.41%post 55.28delayed

Price

32.08▼−6.56%post 32.08delayed

$7.3B

Mkt cap

$9.7B

Q2 FY26$75M

Revenue

$264MQ2 FY26

FY25$235M

Revenue

—

HUT55.00▼−7.41%vsCAI32.08▼−6.56%After hoursNov 2 '26delayed